News

Oscar Health, Inc. recently amended and restated its employment agreement with co-founder Mario Schlosser as he moved from President of Technology and Chief Technology Officer to Co-Founder & Advisor to the CEO, effective June 1, 2026, while he continues to support the company’s artificial intelligence and digital health agenda and remains on the Board. At the same time, a major Wall Street firm upgraded its view on Oscar Health after Q1 2026 results exceeded expectations and reinforced...

Wells Fargo raises price target on Oscar Health stock to $20. Here’s why the bank turned bullish on OSCR shares.

Broadcom downgraded, UnitedHealth upgraded: Wall Street's top analyst calls

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?

Oscar Health’s tech-driven growth contrasts with UnitedHealth’s massive scale and diversified revenue.

Investors are still underappreciating the potential for this healthcare company's growth.

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.

Shares trade up 53% so far in 2026, but they are still underappreciated by investors.

Shares of health insurance company Oscar Health (NYSE:OSCR) fell 3.3% in the morning session after the company's Chief Financial Officer, Richard Blackley, sold $2.75 million in company stock, a move that can sometimes worry investors about a company's outlook.

Oscar Health (OSCR) has been in focus after the Centers for Medicare & Medicaid Services cut user fees for Affordable Care Act marketplaces, alongside first quarter results that included 147% net income growth and 52% revenue growth year over year. See our latest analysis for Oscar Health. The CMS fee cuts and strong first quarter figures have coincided with a sharp shift in sentiment, with Oscar Health posting a 37.71% 1 month share price return and a 59.77% 1 year total shareholder return...

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.

Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?

Oscar Health Inc. (NYSE:OSCR) is one of the 10 Stocks Dominating With Powerful Gains. Oscar Health climbed to a new five-year high on Monday, as investors resumed buying positions in its stock after the Centers for Medicare & Medicaid Services (CMS) formally lowered user fees for the Affordable Care Act (ACA) marketplaces. In intra-day trading, […]

Oscar Health stock hasn't looked back after reporting Q1 earnings that more than doubled from the year-ago quarter.

Oscar Health (NYSE:OSCR) has appointed Siddhartha Sankaran as Independent Chair of the Board. The company has introduced new affordable health insurance products in multiple U.S. regions. These developments reflect ongoing changes in leadership and product offerings beyond routine disclosures. Oscar Health operates in the U.S. health insurance sector, focusing on individual and family coverage supported by technology driven member services. The appointment of an Independent Chair can...

Oscar Health’s first quarter results prompted a positive market reaction as management delivered substantial improvements in profitability, even as revenue came in below consensus. CEO Mark Bertolini attributed the performance to disciplined expense management, robust membership growth, and the growing impact of artificial intelligence (AI) across operations. Notably, Oscar’s medical loss ratio improved sharply, and management highlighted the effectiveness of new technology-driven transparency t

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some may still have unproven business models, leaving them vulnerable to the ebbs and flows of the broader market.

Oscar Health Inc. (NYSE:OSCR) is one of the 10 Stocks With Stunning Gains. Oscar Health extended its winning streak to a 5th straight session on Tuesday to hit a seven-month high, as investors resumed buying positions following a stellar first-quarter performance, having more than doubled its net income during the period. At intra-day trading, the […]

Klaviyo delivers cloud-based marketing automation tools to businesses worldwide, powering personalized digital communications at scale.

Shareholders of Oscar Health, Inc. ( NYSE:OSCR ) will be pleased this week, given that the stock price is up 13% to...

MURGY vs. OSCR: Which Stock Is the Better Value Option?

Oscar Health, Inc. has already reported its first-quarter 2026 results, posting revenue of US$4.65 billion and net income of US$679.00 million, with basic earnings per share from continuing operations of US$2.28. The quarter marked record profitability for the company, with management highlighting technology-led membership growth and reaffirming full-year 2026 guidance despite revenue finishing below consensus expectations. Now we’ll examine how Oscar’s record quarterly earnings and...

Moby summary of Oscar Health, Inc.'s Q1 2026 earnings call

Health care stocks were higher late Wednesday afternoon, with the NYSE Health Care Index increasing

Need a quote from a Motley Fool analyst? Mark Bertolini, Oscar Health's Chief Executive Officer; and Scott Blackley, Oscar Health's Chief Financial Officer, will host this morning's call. This call can also be accessed through our Investor Relations website at ir.hioscar.com.

AMD upgraded, Reddit downgraded: Wall Street's top analyst calls

Oscar Health (NYSE:OSCR) surged nearly 11% in premarket trading on Wednesday after the company reported first-quarter earnings far above Wall Street expectations, driven by strong profitability gains and improving operating margins. The health insurance provider posted adjusted earnings per share of $2.

Oscar Health (OSCR) delivered earnings and revenue surprises of +71.07% and -5.02%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Health insurance company Oscar Health (NYSE:OSCR) missed Wall Street’s revenue expectations in Q1 CY2026, but sales rose 52.6% year on year to $4.65 billion. Its GAAP profit of $2.07 per share was 75.1% above analysts’ consensus estimates.